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Abstract 35 
The centrosomal protein-55 kDa (CEP55 [OMIM 610000]) plays a fundamental role in cell 36 
cycle regulation and cytokinesis. However, the precise role of CEP55 in human embryonic 37 
growth and development is yet to be fully defined. Here we identified a novel homozygous 38 
founder frameshift variant in CEP55, present at low frequency in the Amish community, in 39 
two siblings presenting with a lethal fetal disorder. The features of the condition are 40 
reminiscent of a Meckel-like syndrome comprising of Potter sequence, hydranencephaly and 41 
cystic dysplastic kidneys. These findings, considered alongside two recent studies of single 42 
families reporting loss of function candidate variants in CEP55, confirm disruption of CEP55 43 
function as a cause of this clinical spectrum and enable us to delineate the cardinal clinical 44 
features of this disorder, providing important new insights into early human development.  45 
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Introduction 51 
CEP55 is a centrosome- and midbody-associated protein that has been shown to play 52 
a central role in cell cycle regulation and is recognised as a key protein involved in the 53 
abscission process, the final stage of cytokinesis. (1-3).  CEP55 facilitates abscission through 54 
the recruitment of two ESCRT (endosomal sorting complex required for transport)-I subunit 55 
associated proteins to the midbody: tumor susceptibility gene 101 (TSG101) and apoptosis-56 
linked gene 2 interacting protein X (ALIX) (4). The transcribed CEP55 centrosomal protein 57 
has three central coiled-coil domains and is expressed at the perinuclear membrane, 58 
cytoplasm, and nucleus (2, 5).   59 
Recently candidate homozygous nonsense variants in CEP55 have been identified in 60 
five fetuses from two families in association with a lethal disorder, the features of which 61 
include dysplastic kidneys and complex brain malformations (6, 7).  Homozygous cep55l 62 
knockout mutant zebrafish display a significant reduction in the size of brain structures, and a 63 
decreased number of renal tubules, consistent with the human phenotype (6). 64 
Here we describe a novel Amish homozygous founder frameshift CEP55 variant in 65 
two affected Amish fetuses presenting with hydranencephaly and Potter sequence secondary 66 
to cystic renal dysplasia and anhydramnios.  67 
 68 
Materials and methods 69 
Samples were taken with informed consent (University of Arizona protocol 10-0050-70 
01) for DNA extraction. SNP genotyping was performed using the HumanCytoSNP-12 v2.1 71 
beadchip array (Illumina). Whole exome sequencing (WES) analysis (NextSeq500: Illumina) 72 
involved: Agilent Sureselect Whole Exome v6 targeting, read alignment (BWA-MEM 73 
(v0.7.12), mate-pairs fixed and duplicate removal (Picard v1.129), InDel realignment / base 74 
quality recalibration (GATK v3.4-46), SNV/ InDel detection (GATK HaplotypeCaller), 75 
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annotation (Alamut v1.4.4) and read depth (GATK DepthOfCoverage). Dideoxy sequencing 76 
was undertaken using standard techniques.  The CEP55 variant (NM_018131.4: c.514dup; 77 
p.(Ile172Asnfs*17) and associated phenotype data was submitted to ClinVar  78 
(www.ncbi.nlm.nih.gov/clinvar, accession SCV000808984). 79 
 80 
Results 81 
Subjects 82 
An Ohio Amish couple, distantly related through a 4th generation common ancestor 83 
(Figure 1B), presented in their second pregnancy with dichorionic diamniotic twins, one male 84 
(twin A) and one female (twin B). Antenatal ultrasound scanning (USS) undertaken at 21+2  85 
weeks gestation revealed twin B to have hydranencephaly, a multicystic dysplastic right 86 
kidney (the left kidney was not visualised), shortened bowed long bones and anhydramnios. 87 
Twin A was found to have bilateral renal pelvis dilatation, but no further abnormalities were 88 
detected. A subsequent USS undertaken at 28 weeks gestation to further examine twin B 89 
revealed intrauterine growth restriction (IUGR) and pericardial effusion, the bladder and 90 
stomach were not identified.  The twins were born following an uncomplicated spontaneous 91 
vaginal delivery at 42 weeks gestation. Twin B survived for 90 minutes after birth; the 92 
clinical features of Potter Sequence with cutaneous syndactyly were documented (Figure 1C). 93 
The couple had previously experienced a stillbirth of a male fetus at 42 weeks gestation. The 94 
fetus presented with multiple fetal anomalies at 19 weeks gestation. Anomalies included: 95 
IUGR, anhydramnios, hydranencephaly, described as ‘hydrocephalus seen throughout the 96 
cranium’, and bilateral hydronephrosis. The fetal birth weight was 3lb 14oz and features of 97 
Potter sequence, bilateral lower limb bowing, talipes and syndactyly were identified. (Figure 98 
1C).  Karyotyping of placental samples was normal but post-mortem (PM) examination was 99 
declined for both fetuses.  Assuming that a founder variant was responsible for the condition, 100 
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we used a combination of autozygosity mapping and whole exome sequencing to study this 101 
novel syndrome and identify the underlying molecular cause. 102 
 103 
Genetic studies 104 
Whole genome SNP genotyping of both twins identified a number of homozygous genomic 105 
regions particular to the affected individual, the largest of which was a 20Mb region of 106 
10q22.3-q24.1 (rs1769756- rs7081796, chr10:g.79164647-99204526 [hg38]). Subsequent 107 
whole exome sequencing of DNA from the affected twin excluded previously described 108 
Amish founder variants associated with cystic kidney disease, including NPHP3 (8). Rare 109 
variants predicted to have a functional consequence were cross-referenced with SNP 110 
genotyping data, identifying a single candidate homozygous variant of relevance to the 111 
phenotype.  This variant (NM_018131.4: c.514dup; p.(Ile172Asnfs*17),  112 
chr10:g.93507042dup, [hg38]) in CEP55,  predicted to result in a premature stop, is within 113 
the chromosome 10 locus.  It is present in a single heterozygote in gnomAD and not listed in 114 
ClinVar, NCBI or HGMDpro databases. Dideoxy sequencing confirmed the presence and 115 
cosegregation of the variant (Figure 1B). 179 samples from healthy Amish adults were 116 
analysed and seven heterozygous carriers were identified, corresponding to an estimated 117 
allele frequency of 0.02 in this population.  118 
 119 
Discussion 120 
This is the third reported family with likely homozygous loss of function variants in 121 
CEP55 identified in association with a lethal fetal disorder (comparison of cases; Table 1). 122 
Frosk et al. reported a family with Dutch-German Mennonite ancestry and three affected 123 
fetuses homozygous for a CEP55 nonsense variant (NM_018131.4) c.1274C>A; p.Ser425* 124 
presenting with dysplastic kidneys hydraencephaly, cerebellar hypoplasia and multinucleated 125 
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neurones at PM (6). The authors termed this disorder MARCH syndrome (multinucleated 126 
neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia and hydranencephaly 127 
syndrome [OMIM 236500]) and highlighted an additional nine cases in the literature with 128 
phenotypic overlap including features of hydranencephaly, renal dysplasia and syndactyly (9-129 
13).  However, as far as we are aware, CEP55 genetic analysis has not been undertaken in 130 
these individuals. Interestingly in two cases neuropathological PM findings identified 131 
multinucleated neurons (9, 10).  Bondeson et al. reported a Swedish couple with two affected 132 
fetuses homozygous for CEP55 c.256C>T; p.Arg86* (NM_018131.4) with features in one 133 
including: hydranencephaly, enlarged cystic kidneys, oligohydramnios and cystic hygroma 134 
(7). The second fetus had a slightly different phenotype comprising occipital encephalocele, 135 
cerebral cyst and cystic hygroma, the kidneys were severely degraded due to fetal autolysis. 136 
PM examination was only possible for one fetus and, although neither were identified to have 137 
polydactyly or liver abnormalities, the authors classified the combination of clinical features 138 
as a Meckel-like syndrome.   139 
All seven cases described with biallelic CEP55 variants display phenotypical 140 
similarity, with renal dysplasia or cysts resulting in oligohydramnios and Potter sequence, 141 
and central nervous system (CNS) abnormalities comprising hydranencephaly or cerebral 142 
cysts, as the cardinal clinical features (Table 1). Interestingly, as noted by Bondeson et al., 143 
the presence of these two congenital anomalies fulfils two of the characteristic Meckel 144 
syndrome (MKS) clinical triad (7).  However, in the absence of polydactyly, none of the 145 
seven cases described to date fulfil the triad. Although PM examination was undertaken in 146 
only three cases, hepatic ductal plate malformation, a frequent finding in classical MKS, was 147 
not identified. Occipital encephalocele, the most frequent CNS abnormality in MKS (83.8% 148 
of cases) (14), was documented in one fetus (7).  A spectrum of other CNS abnormalities 149 
have been described in MKS cases, including cerebral cysts and hydrocephalus, of which 150 
7 
 
hydranencephaly can be considered a severe form. Several other features reported in MKS 151 
were identified in this patient cohort, including syndactyly, hydronephrosis, and short bowed 152 
limbs. In view of the wide variability seen in MKS, the lack of diagnostic criteria, and the 153 
phenotypic overlap with CEP55 patients, this disorder should be considered a MKS-like 154 
condition (7).    155 
The Amish siblings described here enable us to more precisely delineate the clinical 156 
consequences of CEP55 loss-of-function, with hydranencephaly and cystic renal dysplasia as 157 
the predominant features. The identification of seven additional Amish control samples 158 
heterozygous for the CEP55 frameshift variant highlights the importance of testing when an 159 
Amish affected fetus presents with Potter sequence or an MKS-like phenotype. Antenatal 160 
USS and PM investigations following stillbirth or neonatal death are infrequently undertaken 161 
by the Amish, and despite no previous reports, the allele frequency suggests that the 162 
condition is under recognised. 163 
Unfortunately, while no tissue was available for cerebral histological analysis from 164 
the Amish and Bondeson cases (7), all three Frosk cases (6) displayed multinucleated neurons 165 
in cerebral tissue, and in one case multinucleated hepatocytes. Disruption of the CEP55 166 
binding site for TSG101 and ALIX likely results from both the p.Arg86* and 167 
p.(Ile172Asnfs*17) variants (Figure 1A), which may prevent the cytokinesis abscission 168 
process resulting in incomplete cell division, providing a plausible explanation for the 169 
multinucleated neurons. The c.256C>T; p.Arg86* variant, located in exon 3 would be 170 
predicted to result in nonsense mediated mRNA decay, however studies on heterozygous 171 
parents identified equal levels of wild type and truncated transcript (7). The p.Ser425* variant 172 
is predicted to delete the terminal 40 amino acids critical for localisation during cytokinesis. 173 
Consistent with this, subcellular localisation studies showed the variant disrupts localisation 174 
to the midbody during cell division (6).  175 
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The lack of development of cerebral structures suggests that loss of CEP55 function 176 
may also play a role in cell migration during embryogenesis and development. Impaired 177 
cytokinesis may contribute to impaired neuronal migration in cells with aberrant cellular 178 
division, potentially explaining the MKS-like phenotype as both impaired cilia function and 179 
cell division processes may cause abnormal neuronal migration. However further studies of 180 
CEP55 function are required to fully determine the precise pathomolecular basis of this lethal 181 
multisystem congenital anomaly disorder. Taken together, our findings consolidate CEP55 as 182 
a molecule fundamental to normal human development, with homozygous loss of function 183 
associated with a Meckel-like lethal fetal disorder profoundly affecting brain and kidney 184 
development.   185 
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Figure Legends  241 
FIGURE 1: CEP55 variants, family pedigree, genotype and images of affected 242 
individuals  243 
(A) Schematic representation indicating the position of the disease-associated CEP55 gene 244 
variants in relation to genomic organisation with the CEP55 c.514dup; p.(Ile172Asnfs*17) 245 
variant identified in the current study highlighted by red text (exons; coloured boxes, introns; 246 
black lines). The correlation between coding regions and CEP55 polypeptide functional 247 
domains is also indicated; tumor suppressor gene 101 (TSG101) and apoptosis-linked gene 2 248 
interacting protein X (ALIX) binding domains (green), and terminal region of the protein 249 
involved in localisation during cytokinesis (yellow). (B) Simplified pedigree of the Amish 250 
family investigated, with electropherograms showing the DNA sequence at the position of the 251 
CEP55 variant (c.514dup) confirmed as homozygous in affected twin B and the deceased 252 
male sibling, and heterozygous in both parents and unaffected twin A. CEP55 genotype is 253 
shown in red under electropherograms in generations V and VI (+, c.514dup; –, WT) (C-H) 254 
Clinical features of individuals homozygous for the CEP55 variant (c.514dup). (C-E) VI:1 255 
showing features of Potter sequence (also known as oligohydramnios sequence and used to 256 
describe a combination of distinctive facial and other associated phenotypic features that are 257 
a result of too little amniotic fluid. Features include epicanthic folds, retrognathia, a flattened 258 
nose, low-set ears, pulmonary hypoplasia and limb contractures including talipes) (15).   259 
Additional features observed included bilateral 2-5 toe syndactyly with a widened first wen 260 
space and a bulbous nasal tip. (F-H) VI:3 (Twin B) showing features of Potter sequence. The 261 
features of both affected fetuses that can be attributed as secondary to oligohydramnios 262 
include redundant skin folds, short neck, flattened face, short pinched nose, retrognathia, 263 
small palpebral fissures and low set ears, brachydactyly, tapering fingers, and short 5th fingers 264 
with clinodactyly. 265 
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 266 
Table Legends  267 
TABLE 1: Comparison of cases with biallelic CEP55 variants 268 
Abbreviations: TOP, termination of pregnancy; IUFD, intrauterine fetal death; SB, stillbirth; 269 
ND, neonatal death; CNS, central nervous system. (+), indicates presence of a feature in an 270 
affected subject; (-), indicates absence of a feature in an affected subject); n/k, not known; 271 
n/a, not available. 272 
 273 

CASE Bondesen 
et al. 
Bondesen 
et al. 
Frosk et al. Frosk et al. Frosk et al. Individual Individual 
Patient II:2 II:3 303 305 306 VI:1 VI:3 
CEP55 (NM_018131.4) 
Genotype 
c.256C>T 
p.Arg86* 
c.256C>T 
p.Arg86* 
c.1274C>A 
p.S425* 
c.1274C>A 
p.S425* 
c.1274C>A 
p.S425* 
c.514dup 
p.(Ile172Asnfs*17) 
c.514dup 
p.(Ile172Asnfs*17) 
Sex M M M M M M F 
Pregnancy outcome 
(gestation) 
TOP 
(20) 
IUFD 
(14+6) 
SB 
(30) 
ND 
(35) 
SB 
(32) 
SB 
(42) 
ND 
(42) 
Gestation anomalies 
identified 
19 + 4 10 + 4 20 n/k n/k 19 21 + 2 
        
POTTER SEQUENCE n/a n/a + + + + + 
        
RENAL FEATURES        
Renal aplasia/dysplasia  + n/k + + + n/k + 
Ureteral agenesis n/k n/k + + + n/k n/k 
Renal cysts + n/k - - - n/k + 
Bilateral hydronephrosis +/- n/k - - - + - 
Oligohydramnios + n/a + + + + + 
Pulmonary hypoplasia n/k n/k + + + n/k n/k 
Contractures - n/a + + + - + 
Talipes + n/a + + + + + 
        
CNS FEATURES        
Hydranencephaly + - + + + + + 
Cerebral cysts - + - - - - - 
Cerebellar hypoplasia + n/k + + + n/k n/k 
Encephalocele - + - - - - - 
Multinucleated neurons n/k n/k + + + n/k n/k 
Skull asymmetry + - - - - - - 
        
GROWTH        
IUGR + n/k n/a n/a n/a + + 
        
CARDIAC FEATURES        
Dysplastic aortic valve n/k n/k + n/k + n/k n/k 
Dilated left ventricle n/k n/k + n/k + n/k n/k 
Pericardial effusion  n/k n/k - - - - + 
        
SKELETAL 
FEATURES 
       
Shortened/bowed long 
bones 
n/k n/a - - - + + 
Vertebral abnormalities n/k n/a + + - n/k n/k 
        
OTHER FEATURES        
Cystic hygroma + + + + + - - 
Redundant neck skin n/a n/a + + + + + 
Bulbous nasal tip n/k n/a + + + + + 
Syndactyly n/a n/a + + + + + 
Brachydactyly n/a n/a + + + + + 
Widened first web space n/a n/a + + + + + 
Single umbilical artery  + n/a - - - - + 
        
 
